XML 38 R28.htm IDEA: XBRL DOCUMENT v3.22.1
Net Income (Loss) Per Share
3 Months Ended
Mar. 31, 2022
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]  
Net Income (Loss) Per Share
22.
NET INCOME (LOSS) PER SHARE

The Company calculates basic earnings per share by dividing the net income (loss) by the weighted average number of shares of common stock outstanding for the period. The diluted earnings per share is computed by assuming the exercise, settlement and vesting of all potential dilutive common stock equivalents outstanding for the period using the treasury stock method. The Company excludes common stock equivalent shares from the calculation if their effect is anti-dilutive. In a period where the Company is in a net loss position, the diluted loss per share is calculated using the basic share count.

The 8,625,000 Sponsor Vesting Shares that are issued and outstanding at March 31, 2022 are excluded from the weighted average number of shares of common stock outstanding until the vesting requirement is met and the restriction is removed.

The following table sets forth a reconciliation of the numerator and denominator used to compute basic and diluted earnings per share of common stock (in thousands, except for share and per share data).

 

 

 

For the Three Months Ended

 

 

 

March 31,

 

 

 

2022

 

 

2021

 

Numerator

 

 

 

 

 

 

Net income (loss)

 

$

11,975

 

 

$

(5,084

)

Denominator

 

 

 

 

 

 

Weighted average shares of common stock - basic

 

 

603,104,839

 

 

 

505,072,914

 

Dilutive effect of stock-based awards

 

 

37,923,571

 

 

 

 

Weighted average shares of common stock - diluted

 

 

641,028,410

 

 

 

505,072,914

 

Net income (loss) per share:

 

 

 

 

 

 

Basic

 

$

0.02

 

 

$

(0.01

)

Diluted

 

$

0.02

 

 

$

(0.01

)

 

Common stock equivalent shares of approximately 110,393 and 18,091,415 were excluded from the computation of diluted per share amounts for the three months ended March 31, 2022 and 2021, respectively, because their effect was anti-dilutive.